Cowden disease

doi:10.1017/CBO9780511545054.017

15 - Cowden disease

Published online by Cambridge University Press: 31 July 2009

G. W. Padberg

Edited by

E. Steve Roach and

Van S. Miller

Show author details

G. W. Padberg: Affiliation:
Department of Neurology, University Hospital Nijmegen, The Netherlands
E. Steve Roach: Affiliation:
Wake Forest University, North Carolina
Van S. Miller: Affiliation:
University of Texas Southwestern Medical Center, Dallas

Book contents

Get access

Summary

Introduction

Cowden disease (CD; MIM158350) is a rare disorder, with an incidence of 1 in 400 000 in the Netherlands. Easily recognizable in its classic form, it is often overlooked in its common presentation unless one is attentive to its harmless-looking skin features or to a family history of multiple and different malignancies. Not described as an independent disease entity before 1962, the authors named the disease after their first patient (Lloyd & Dennis, 1963). Undoubtedly, similar patients had been reported before, but the dermatological features which came to define the disease had not been recognized (Ambler et al., 1969). Subsequent studies characterized the disease as a genodermatosis with autosomal dominant inheritance. The mesodermal and endodermal hamartomatous lesions were soon recognized as part of CD, leading to the name multiple hamartoma syndrome (Weary et al., 1972).

Gradually attention shifted to the malignant tendency of some of these tumors. The high incidence of macrocephaly had been mentioned before, but the frequent presence of mild neurological signs, the megalencephaly, and the recognition of the dysplastic cerebellar gangliocytoma as a characteristic central nervous system lesion led us to redefine CD as a phakomatosis (Padberg et al., 1991). By analogy, its gene was expected to be a tumor-suppressor gene involved in apoptosis and cellular growth regulation pathways, and its possible significance was compared to the Li–Fraumeni gene p53. The discovery of PTEN as the CD-gene in 1998 and the subsequent flood of papers on the function of PTEN proved this prediction to be correct.

Information

Type: Chapter
Information: Neurocutaneous Disorders , pp. 131 - 137

DOI: https://doi.org/10.1017/CBO9780511545054.017 [Opens in a new window]

Publisher: Cambridge University Press

Print publication year: 2004

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Book purchase

Temporarily unavailable

References

Ambler, M., Pogacar, A. & Sidman, R. (1969). Lhermitte–Duclos disease (Granule-cell hypertrophy of the cerebellum). Pathological analysis of the first familial case. Journal of Neuropathology and Experimental Neurology, 28: 622–647CrossRef Google Scholar

Bagan, J. V., Peanrrocha, M. & Vera, S. (1989). Cowden syndrome: clinical and pathological considerations in two new cases. Journal of Oral and Maxillofacial Surgery, 47: 291–294CrossRef Google Scholar PubMed

Bostrom, J., Cobbers, J. M., Wolter, M. et al. (1998). Mutation of the PTEN (MMAC1) tumor suppressor gene in a subset of glioblastomas but not in meningiomas with loss of chromosome arm 10q. Cancer Research, 58: 29–33Google Scholar

Cairns, P., Okami, K., Halachmi, S. et al. (1997). Frequent inactivation of PTEN/MMAC1 in primary prostate cancer. Cancer Research, 57: 4997–5000Google Scholar PubMed

Di Cristofano, A. & Pandolfi, P. P. (2000). The multiple roles of PTEN in tumor suppression. Cell, 100: 387–390CrossRef Google Scholar PubMed

Di Cristofano, A., Pesce, B., Cordon-Cardo, C. & Pandolfi, P. P. (1998). PTEN is essential for embryonic development and tumour suppression. Nature Genetics, 19: 348–355CrossRef Google Scholar PubMed

Goberdhan, D. C., Paricio, N., Goodman, E. C., Mlodzik, M. & Wilson, C. (1999). Drosophila tumor suppressor PTEN controls cell size and number by antagonizing the Chico/P13-kinase signaling pathway. Genes and Development, 13: 3244–3258CrossRef Google Scholar

Guldberg, P., Thor Straten, P., Birck, A., Ahrenkiel, V., Kirkin, A. F. & Zeuthen, J. (1997). Disruption of the MMAC1/PTEN gene by deletion or mutation is a frequent event in malignant melanoma. Cancer Research, 57: 3660–3663Google Scholar PubMed

Jiang, B-H., Zheng, J. Z., Aoki, M. & Vogt, P. K. (2000). Phosphatidylinositol 3-kinase signaling mediates angiogenesis and expression of vascular endothelial growth factor in endothelial cells. Proceedings of the National Academy of Sciences, USA, 97: 1749–1753CrossRef Google Scholar PubMed

Kong, D., Suzuki, A., Zou, T. T. et al. (1997). PTEN1 is frequently mutated in primary endometrial carcinomas. Nature Genetics, 17: 143–144CrossRef Google Scholar PubMed

Kulkantrakorn, K., Awwad, E. E., Levy, B. et al. (1997). MRI in Lhermitte–Duclos disease. Neurology, 48: 725–731CrossRef Google Scholar PubMed

Levine, R. L., Cargile, C. B., Blazes, M. S., Rees, B., Kurman, R. J. & Ellenson, L. H. (1998). PTEN mutation and microsatelitte instability in compex atypical hyperplasia, a precursor lesion to uterine endometriod carcinoma. Cancer Research, 58: 3254–3258Google Scholar

Lhermitte, J. & Duclos, P. (1920). Sur un ganglioneurome diffus du cortex du cervelet. Bulletin de L'Association Francaise pour l'etude du cancer, 9: 99–107Google Scholar

Li, D. M. & Sun, H. (1997). TEP1, encoded by a candidate tumor suppressor locus, is a novel protein tyrosine phosphatase regulated by transforming growth factor beta. Cancer Research, 57: 2124–2129Google Scholar PubMed

Li, D. M. & Sun, H. (1998). PTEN/MMAC1/T EP1 suppresse the tumrorigenicity and induces G(1) cell cycle arrest in human glioblastoma cells. Proceedings of the National Academy of Sciences, USA, 95: 15406–15411CrossRef Google Scholar

Li, J., Yen, C., Liaw, D. et al. (1997a). PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science, 275: 1943–1947CrossRef Google Scholar

Liaw, D., Marsh, D. J., Li, J. et al. (1997b). Germline mutations of PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome. Nature Genetics, 16: 64–67CrossRef Google Scholar

Liu, W., James, C. D., Frederick, L., Alderete, B. E. & Jenkins, R. B. (1997c). PTEN/MMAC1 mutations and EGFR amplification in glioblastomas. Cancer Research, 57: 5254–5257Google Scholar

Lloyd, K. M. & Dennis, M. (1963). Cowden's Disease: a possible new symptom complex with multiple system involvement. Annals of Internal Medicine, 58: 136–142CrossRef Google Scholar PubMed

Lowichik, A., White, F. V., Timmons, C. F. et al. (2000). Bannayan–Riley–Ruvalcaba syndrome: spectrum of intestinal pathology including juvenile polyps. Pediatric and Developmental Pathology, 3: 155–161CrossRef Google Scholar PubMed

Lynch, E. D., Ostermeyer, E. A., Lee, M. K. et al. (1997). Inherited mutations in PTEN that are associated with breast cancer, Cowden disease, and juvenile polyposis. American Journal of Human Genetics, 61: 1254–1260CrossRef Google Scholar PubMed

Lyons, C. J., Wilson, C. B. & Horton, J. C. (1993). Association between meningioma and Cowden disease. Neurology, 43: 1436–1437CrossRef Google Scholar

Marsh, D. J., Dahia, P. L., Zheng, Z. et al. (1997). Germline mutations in PTEN are present in Bannayan-Zonana syndrome. Nature Genetics, 16: 333–334CrossRef Google Scholar PubMed

Marsh, D. J., Coulon, V., Lunetta, K. L. et al. (1998). Mutation spectrum and genotype-phenotype analyses in Cowden disease and Bannayan–Zonana syndrome, two hamartoma syndromes with germline PTEN mutation. Human Molecular Genetics, 7: 507–515CrossRef Google Scholar PubMed

Mollenhauer, J., Wiemann, S., Scheurlen, W. et al. (1997). DMBT1, a new member of the SRCR superfamily, on chromosome 10q25.3–23.6 is deleted in malignant brain tumours. Nature Genetics, 17: 32–39CrossRef Google Scholar PubMed

Myers, M. P., Pass, I., Batty, I. H. et al. (1998). The lipid phosphatase activity of PTEN is critical for its tumor suppressor function. Proceedings of the National Academy of Sciences, USA, 95: 13513–13518CrossRef Google Scholar

Nelen, M. R., Padberg, G. W., Peeters, E. A. et al. (1996). Localization of the gene for Cowden disease to chromosome 10q22–23. Nature Genetics, 13: 114–116CrossRef Google Scholar PubMed

Nelen, M. R., Staveren, W. C., Peeters, E. A. et al. (1997). Germline mutations in the PTEN MMAC1 gene in patients with Cowden disease. Human Molecular Genetics, 6: 1383–1387CrossRef Google Scholar PubMed

Nelen, M. R., et al. (2003). Expression of the tumor suppressor gene PTEN/MMAC1 in mouse during embryonic and postnatal brain development. Brain Research (accepted for publication)

Olschwang, S., Serova-Sinilnikova, O. M., Lenoir, G. M. & Thomas, G. (1998). PTEN germline mutations in juvenile polyposis coli. Nature Genetics 18: 12–14CrossRef Google Scholar PubMed

Padberg, G. W., Schot, J. D., Vielvoye, G. J., Bots, G. T. & Beer, F. C. (1991). Lhermitte–Duclos disease and Cowden Disease: a single phakomatosis. Annals of Neurology, 29: 517–523CrossRef Google Scholar PubMed

Podsypanina, K., Ellenson, L. H., Nemes, A. et al. (1999). Mutation of PTEN/MMAC1 in mice causes neoplasia in multiple organ systems. Proceedings of the National Academy of Sciences, 96: 1563–1568CrossRef Google Scholar PubMed

Starink, T. M. (1984). Cowden's disease: analysis of fourteen new cases. Journal of the American Academy of Dermatology, 11: 1127–1141CrossRef Google Scholar PubMed

Starink, T. M., Veen, J. P., Arwert, F. et al. (1986). The Cowden syndrome: a clinical and genetic study in 21 patients. Clinical Genetics, 29: 226–233Google Scholar PubMed

Steck, P. A., Pershouse, M. A., Jasser, S. A. et al. (1997). Identification of a candidate tumour suppressor gene, MMAC1 at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nature Genetics, 15: 356–362CrossRef Google Scholar PubMed

Suzuki, A., Pompa, J. L., Stambolic, V. et al. (1998). High cancer susceptibility and embryonic lethality associated with mutation of the PTEN tumor suppressor gene in mice. Currrent Biology, 8: 1169–1178CrossRef Google Scholar PubMed

Tohma, Y., Gratas, C., Biernat, W. et al. (1998). PTEN (MMAC1) mutations are frequent in primary glioblastomas (de novo) but not in secondary glioblastomas. Journal of Neuropathology and Experimental Neurology, 57: 684–689CrossRef Google Scholar PubMed

Tok Celebi, J., Chen, F. F., Zhang, H., Ping, X. L., Tsou, H. C. & Peacocke, M. (1999). Indentification of PTEN mutations in five families with Bannayan–Zonana syndrome. Experimental Dermatology, 8: 134–139CrossRef Google Scholar

Vinchon, M., Blond, S., Lejeune, J. P. et al. (1994). Association of Lhermitte–Duclos and Cowden disease: report of a new case and review of the literature. Journal of Neurology, Neurosurgery and Psychiatry, 57: 699–704CrossRef Google Scholar PubMed

Weary, P. E., Gorlin, R. J., Gentry, W. C. Jr., Comer, J. E. & Greer, K. E. (1972). Multiple hamartoma syndrome (Cowden's disease). Archives of Dermatology, 106: 682–690CrossRef Google Scholar

Zhou, X. P., Marsh, D. J., Hampel, H., Mulliken, J. B., Gimm, O., Eng, C. (2000). Germline and germline mosaic PTEN mutations associated with a Proteus-like syndrome of hemihypertrophy, lower limb asymmetry, arteriovenous malformations and lipomatosis. Human Molecular Genetics, 9: 765–768CrossRef Google Scholar PubMed

Accessibility standard: Unknown

Why this information is here

This section outlines the accessibility features of this content - including support for screen readers, full keyboard navigation and high-contrast display options. This may not be relevant for you.

Accessibility Information

Accessibility compliance for the PDF of this chapter is currently unknown and may be updated in the future.